首页 | 本学科首页   官方微博 | 高级检索  
     

单用二甲双胍血糖控制不良的早期2型糖尿病患者加用西格列汀疗效观察
引用本文:郑恂,吕英俊. 单用二甲双胍血糖控制不良的早期2型糖尿病患者加用西格列汀疗效观察[J]. 中国临床保健杂志, 2013, 16(4): 363-364
作者姓名:郑恂  吕英俊
作者单位:郑恂 (武警浙江省总队医院内分泌科,嘉兴,314000); 吕英俊 (武警浙江省总队医院内分泌科,嘉兴,314000);
摘    要:目的观察单用二甲双胍血糖控制不佳的早期2型糖尿病(T2DM)患者加用二肽基肽酶-Ⅳ(DPP-4)抑制剂西格列汀治疗的疗效及安全性。方法选择病程3年以内、单用二甲双胍治疗3个月以上、血糖控制不良的T2DM患者24例,加用西格列汀100 mg/d,持续治疗12周,观察治疗前后空腹血糖(FPG)、餐后2小时血糖(2hPG)、糖化血红蛋白(HbA1c)、体质量的变化情况。结果加用西格列汀治疗12周后,FPG、2hPG、HbA1c较前显著下降(P<0.01),体质量无显著变化(P>0.05),治疗期间无严重不良反应发生。结论单用二甲双胍控制不良的早期T2DM患者加用西格列汀安全、有效,患者耐受性好。

关 键 词:糖尿病,2型  二甲双胍  治疗结果  西格列汀

Efficacy of added Sitagliptin therapy in early patients with type 2 diabetes inadequately controlled by Metformin alone
ZHENG Xun,LV Yingjun. Efficacy of added Sitagliptin therapy in early patients with type 2 diabetes inadequately controlled by Metformin alone[J]. Chinese Journal of Clinical Healthcare, 2013, 16(4): 363-364
Authors:ZHENG Xun  LV Yingjun
Affiliation:( Department of Endocrinology,Zhejiang Provincial Corps Hospital of Chinese People's Armed Forces,Jiaxing 314000,China)
Abstract:Objective To observe the eifficacy and safety of dipeptidyl peptidase-4 inhibitor Sitagliptin added to patients with early type 2 diabetes inadequately controlled by metformin alone.Methods 24 patients inadequately controlled with Metformin were enrolled and added with Sitagliptin 100mg once daily for 12 weeks.The levels of fasting plasma glucose(FPG),2 hours postprandial glucose(2hPG),hemoglobin A1c(HbA1c) and weight were compared after treatment.Results FPG,2hPG and HbA1c reduced significantly after treatment of sitagliptin(P 0.01).There was not serious adverse effect happened.Conclusion Sitagliptin added to ongo metformin therapy is efficacious and safe.
Keywords:Diabetes mellitus  type 2  Metformin  Treatment outcome  Sitagliptin
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号